Accelerate Diagnostics Is About To Accelerate Downward- $6 Price...
White Diamond’s proprietary diligence identified new info that suggests Accelerate Diagnostic's (AXDX) Pheno system is only a niche product. The...
Research
(If you're unable to access an article, contact us and we'll email you the full article)
United Health Products Has An Absurd Valuation With Only...
United Health Products reached a $400M market valuation on speculative hopes related to its HemoStyp surgical gauze. UEEC’s only product,...
Discovery Gold Corp. Is A $150M+ Empty Shell, False...
Discovery Gold Corp (DCGD) is a $150M+ empty shell – an unheard of valuation for a shell with no cash,...
Synthesis Energy Systems Is Essentially An Empty Shell With...
Synthesis Energy Systems (SES) has a failed clean energy technology called coal gasification. After years of trying to make it...
Applied Energetics: A Resurrected Failed Weapons Technology Company Is...
Applied Energetics (AERG) became an empty shell in 2014 and remained that way for 2.5 years. There have been no...
BioSig: A Useless Product, A Paid Stock Promotion, And...
Although invented 10 years ago, BioSig’s PURE EP System add-on device has had no published clinical data, only bench and...
Soliton – The Great Reg A+ IPO P&D PR...
Summary Soliton is a Reg A+ IPO, which means they could not get institutional investors, so they had to raise...
The FDA Might Have Inadvertently Implanted Establishment Labs As...
Establishment Labs (ESTA) has taken the breast implant industry by storm with its next level technology, 6th generation, Motiva Implants....
Torchlight Energy: We Believe Its Orogrande Project Is Worthless,...
Torchlight Energy has an enterprise value of over $130M. The company's entire perceived value is based on possible oil in...
Conformis Is A Failed Market Experiment, No Justification For...
We believe the 400% appreciation of Conformis (CFMS) in 2019 is not from any positive fundamental developments, but from hype...
American Superconductor Is A House Of Cards Set To...
American Superconductor stock has risen over 100% since July 2018 on little progress in its businesses. We expect a fade...
Why Hospitals Are Not Buying T2 Biosystems Diagnostic System...
T2 Biosystems’ recent Breakthrough Device designation by the FDA isn’t an acknowledgement of the device’s effectiveness or clinical value proposition,...
Track Record
We have an over 90% success rate
3rd Party Verified:
(click on the stock symbols below to see the reports)
Get Our Latest Reports Delivered To Your Inbox (we will not share your email with anyone)